{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:49:37Z","timestamp":1786128577792,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Athletes are frequently prescribed combination therapies to manage bacterial infections and musculoskeletal injuries, often involving amoxicillin (AMX), ibuprofen (IBU), and chlorzoxazone (CHL). However, their co-administration presents analytical challenges due to the structural diversity of these drugs within complex matrices. Simultaneous quantification of these agents is particularly demanding in the context of pharmacokinetic studies, therapeutic drug monitoring, and pharmaceutical quality control, where sensitivity, selectivity, and matrix compatibility are essential. To address this challenge, the present study introduces a rapid, robust micellar liquid chromatographic (MLC) method demonstrating an environmentally favorable profile relative to conventional acetonitrile-based RP-HPLC comparators, for the simultaneous determination of AMX, CHL, and IBU in their combined pharmaceutical dosage forms, and human plasma samples. The method utilizes a short RP-C18 column i.e., 75\u00a0mm, with UV detection at 220\u00a0nm, achieving complete separation of all three analytes in under 6\u00a0min using a low impact micellar mobile phase composed of sodium lauryl sulfate (SDS), Brij-35, and potassium dihydrogen phosphate at pH 3.0. Method validation was performed according to ICH guidelines, demonstrating linearity (R\u00b2 &gt; 0.999), accuracy (98.6\u2013101.1%), adequate sensitivity (LOD: 0.44\u20130.74\u00a0\u00b5g\/mL; LOQ: 1.32\u20132.25\u00a0\u00b5g\/mL), and excellent baseline resolution between adjacent peaks (Rs\u2009&gt;\u20094.5) across the concentration range of 2.5\u201325\u00a0\u00b5g\/mL for all three analytes. Environmental sustainability was quantitatively assessed; the proposed method achieved an Eco-scale score of 87, compared to 68\u201378 for previously reported RP-HPLC methods, providing a quantitative basis for the green chemistry comparison. In alignment with green chemistry principles, the method\u2019s environmental sustainability was further evaluated using multiple metrics including the Analytical Eco-Scale, GAPI, AGREE, BAGI, and RGB12 tools. The collective results indicate that the proposed method\u2019s environmental profile compares favorably with previously reported RP-HPLC procedures, though it is acknowledged that the applied greenness metrics do not fully capture potential environmental persistence of non-ionic surfactants such as Brij-35 at high concentrations. Within the validated scope, the method demonstrates preliminary suitability for pharmaceutical quality control and therapeutic concentration monitoring; full bioanalytical validation per FDA\/EMA guidance is recommended prior to pharmacokinetic applications. It is acknowledged that acetonitrile use in the plasma preparation step is included in the environmental assessments, and that long-term sustainability of the surfactant system at high concentrations warrants further evaluation.<\/jats:p>","DOI":"10.1038\/s41598-026-64529-1","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:24:22Z","timestamp":1786127062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Organic solvent-free micellar liquid chromatographic determination of amoxicillin, chlorzoxazone, and ibuprofen in pharmaceutical and biological matrices"],"prefix":"10.1038","volume":"16","author":[{"given":"Naglaa A.","family":"Kabil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8905-5843","authenticated-orcid":false,"given":"Mariam","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawa M.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Abdulwahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"1","key":"64529_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/asjsm.34174","volume":"5","author":"Z Ahmadinejad","year":"2014","unstructured":"Ahmadinejad, Z. et al. Common sports-related infections: a review on clinical pictures, management and time to return to sports. Asian J. Sports Med. 5 (1), 1 (2014).","journal-title":"Asian J. sports Med."},{"issue":"2","key":"64529_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1249\/JSR.0b013e3182142381","volume":"10","author":"MD Harris","year":"2011","unstructured":"Harris, M. D. Infectious disease in athletes. Curr. Sports Med. Rep. 10 (2), 84\u201389 (2011).","journal-title":"Curr. Sports Med. Rep."},{"key":"64529_CR3","first-page":"1895","volume":"64","author":"S Sweetman","year":"2009","unstructured":"Sweetman, S. Martindale, the complete drug reference. Thirty Six London 64, 65, 1894, 1895. (2009).","journal-title":"Thirty Six London"},{"key":"64529_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40798-024-00743-3","volume":"10","author":"M Stuart","year":"2024","unstructured":"Stuart, M. et al. The essential and optimal analgesic and anti-inflammatory medicines for athletes at the olympic games. Sports Med. Open. 10, : p. 80. (2024).","journal-title":"Sports Med. - Open."},{"issue":"5","key":"64529_CR5","first-page":"142","volume":"3","author":"M Abou Elmagd","year":"2016","unstructured":"Abou Elmagd, M. Common sports injuries. Int. J. Phys. Educ. sports health. 3 (5), 142\u2013148 (2016).","journal-title":"Int. J. Phys. Educ. sports health"},{"issue":"5","key":"64529_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4102\/safp.v60i5.4912","volume":"60","author":"DCJ van Rensburg","year":"2018","unstructured":"van Rensburg, D. C. J. et al. The use of skeletal muscle relaxants in musculoskeletal injuries: what is the evidence? South. Afr. Family Pract. 60 (5), 7\u201316 (2018).","journal-title":"South. Afr. Family Pract."},{"issue":"15","key":"64529_CR7","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1080\/10826076.2011.629390","volume":"35","author":"ME El-Kommos","year":"2012","unstructured":"El-Kommos, M. E., Mohamed, N. A., Abdel, A. F. & Hakiem Selective reversed phase high performance liquid chromatography for the simultaneous determination of some pharmaceutical binary mixtures containing nsaids. J. Liq. Chromatogr. Relat. Technol. 35 (15), 2188\u20132202 (2012).","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"issue":"7","key":"64529_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1080\/10826076.2011.613142","volume":"35","author":"EF Elkady","year":"2012","unstructured":"Elkady, E. F. & Fouad, M. A. Two liquid chromatographic methods for the simultaneous determination of ibuprofen and methocarbamol or chlorzoxazone in the presence of their degradation products. J. Liq. Chromatogr. Relat. Technol. 35 (7), 882\u2013895 (2012).","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"issue":"2","key":"64529_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.59566\/IJBS.2009.5136","volume":"5","author":"N El-Enany","year":"2009","unstructured":"El-Enany, N. et al. Second derivative synchronous fluorescence spectroscopy for the simultaneous determination of chlorzoxazone and ibuprofen in pharmaceutical preparations and biological fluids. Int. J. Biomed. Sci. IJBS. 5 (2), 136 (2009).","journal-title":"Int. J. biomedical science: IJBS"},{"key":"64529_CR10","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10895-011-1013-1","volume":"22","author":"M Attia","year":"2012","unstructured":"Attia, M. et al. Spectrofluorimetric assessment of chlorzoxazone and Ibuprofen in pharmaceutical formulations by using Eu-tetracycline HCl optical sensor doped in sol\u2013gel matrix. J. Fluoresc. 22, 779\u2013788 (2012).","journal-title":"J. Fluoresc."},{"issue":"4","key":"64529_CR11","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s10895-023-03175-6","volume":"33","author":"NA Abdallah","year":"2023","unstructured":"Abdallah, N. A. et al. Green constant-wavelength concurrent selective fluorescence method for assay of ibuprofen and chlorzoxazone in presence of chlorzoxazone degradation product. J. Fluoresc. 33 (4), 1661\u20131671 (2023).","journal-title":"J. Fluoresc."},{"issue":"1","key":"64529_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jpha.2012.07.005","volume":"3","author":"ME El-Kommos","year":"2013","unstructured":"El-Kommos, M. E., Mohamed, N. A. & Hakiem, A. F. A. Selective micellar electrokinetic chromatographic method for simultaneous determination of some pharmaceutical binary mixtures containing non-steroidal anti-inflammatory drugs. J. Pharm. Anal. 3 (1), 53\u201360 (2013).","journal-title":"J. Pharm. Anal."},{"issue":"2","key":"64529_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/222979282000.10648258","volume":"2","author":"R Joshi","year":"2012","unstructured":"Joshi, R. et al. Simultaneous estimation of paracetamol, chlorzoxazone and ibuprofen by validated spectrophotometric methods. Anal. Chem. Lett. 2 (2), 118\u2013124 (2012).","journal-title":"Anal. Chem. Lett."},{"key":"64529_CR14","doi-asserted-by":"publisher","first-page":"123891","DOI":"10.1016\/j.saa.2024.123891","volume":"310","author":"J Mendonsa","year":"2024","unstructured":"Mendonsa, J., Gandhi, S. & Mahajan, A. Quantification of ternary mixture of paracetamol, chlorzoxazone and ibuprofen present in tablet dosage form using ratio subtraction spectrophotometric approaches. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 310, 123891 (2024).","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"issue":"2","key":"64529_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0039-9140(97)00153-7","volume":"45","author":"VR Bari","year":"1997","unstructured":"Bari, V. R., Dhorda, U. & Sundaresan, M. A simultaneous packed column supercritical fluid chromatographic method for ibuprofen, chlorzoxazone and acetaminophen in bulk and dosage forms. Talanta 45 (2), 297\u2013302 (1997).","journal-title":"Talanta"},{"issue":"6","key":"64529_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0039-9140(98)00043-5","volume":"46","author":"S Ravisankar","year":"1998","unstructured":"Ravisankar, S. et al. Reversed-phase HPLC method for the estimation of acetaminophen, ibuprofen and chlorzoxazone in formulations. Talanta 46 (6), 1577\u20131581 (1998).","journal-title":"Talanta"},{"key":"64529_CR17","doi-asserted-by":"publisher","first-page":"107316","DOI":"10.1016\/j.microc.2022.107316","volume":"178","author":"NH Al-Shaalan","year":"2022","unstructured":"Al-Shaalan, N. H. et al. Use of green-modified micellar liquid chromatography for the determination of imidocarb dipropionate residues in food samples. Microchem. J. 178, 107316 (2022).","journal-title":"Microchem. J."},{"key":"64529_CR18","doi-asserted-by":"crossref","unstructured":"Mukerjee, P. & Mysels, K. Critical micelle concentrations of aqueous surfactant systems. (1971).","DOI":"10.6028\/NBS.NSRDS.36"},{"issue":"6","key":"64529_CR19","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1039\/C5GC00338E","volume":"17","author":"MJ Ruiz-Angel","year":"2015","unstructured":"Ruiz-Angel, M. J., Peris-Garc\u00eda, E. & Garc\u00eda-Alvarez-Coque, M. C. Reversed-phase liquid chromatography with mixed micellar mobile phases of Brij-35 and sodium dodecyl sulphate: a method for the analysis of basic compounds. Green Chem. 17 (6), 3561\u20133570 (2015).","journal-title":"Green Chem."},{"key":"64529_CR20","unstructured":"International Conference on Harmonization (ICH) (2005) Q2B: Validation of Analytical Procedures, Methodology, US FDA, Federal Register, 1, 5."},{"issue":"1","key":"64529_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13065-024-01215-1","volume":"18","author":"YA Salem","year":"2024","unstructured":"Salem, Y. A., Elsabour, S. A. & El-Masry, A. A. Validated chromatographic approach for determination of two ternary mixtures in newly approved formulations for helicobacter pylori eradication: assessment of greenness profile and content uniformity. BMC Chem. 18 (1), 111 (2024).","journal-title":"BMC Chem."},{"key":"64529_CR22","unstructured":"Pharmacopeia, U. United States Pharmacopeia and National Formulary (USP 37\u2013NF 32) (US Pharmacopeia, 2014)."},{"key":"64529_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka, A. et al. Analytical Eco-Scale for assessing the greenness of analytical procedures. TRAC Trends Anal. Chem. 37, 61\u201372 (2012).","journal-title":"TRAC Trends Anal. Chem."},{"key":"64529_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka, J. A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. Talanta 181, 204\u2013209 (2018).","journal-title":"Talanta"},{"issue":"14","key":"64529_CR25","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira, F., Wojnowski, W. & Tobiszewski, M. AGREE\u2014Analytical GREEnness Metric Approach and Software. Anal. Chem. 92 (14), 10076\u201310082 (2020).","journal-title":"Anal. Chem."},{"key":"64529_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mineng.2016.04.015","volume":"94","author":"Y Shen","year":"2016","unstructured":"Shen, Y. et al. Development of Greenness Index as an evaluation tool to assess reagents: Evaluation based on SDS (Safety Data Sheet) information. Miner. Eng. 94, 1\u20139 (2016).","journal-title":"Miner. Eng."},{"issue":"19","key":"64529_CR27","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N. et al. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chem. 25 (19), 7598\u20137604 (2023).","journal-title":"Green Chem."},{"issue":"16","key":"64529_CR28","doi-asserted-by":"publisher","first-page":"10343","DOI":"10.1021\/acs.analchem.9b01872","volume":"91","author":"PM Nowak","year":"2019","unstructured":"Nowak, P. M. & Ko\u015bcielniak, P. What color is your method? Adaptation of the RGB additive color model to analytical method evaluation. Anal. Chem. 91 (16), 10343\u201310352 (2019).","journal-title":"Anal. Chem."},{"issue":"1","key":"64529_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1128\/AAC.11.1.132","volume":"11","author":"DA Spyker","year":"1977","unstructured":"Spyker, D. A. et al. Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration. Antimicrob. Agents Chemother. 11 (1), 132\u2013141 (1977).","journal-title":"Antimicrob. Agents Chemother."},{"key":"64529_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00228-017-2345-9","volume":"74","author":"SK Bedada","year":"2018","unstructured":"Bedada, S. K. & Neerati, P. The effect of quercetin on the pharmacokinetics of chlorzoxazone, a CYP2E1 substrate, in healthy subjects. Eur. J. Clin. Pharmacol. 74, 91\u201397 (2018).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"64529_CR31","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fphar.2014.00098","volume":"5","author":"P Kale","year":"2014","unstructured":"Kale, P. Pharmacokinetics and bioavailability of single dose ibuprofen and pseudoephedrine alone or in combination: a randomized three-period, cross-over trial in healthy Indian volunteers. Front. Pharmacol. 5, 98 (2014).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64529-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64529-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64529-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:30:24Z","timestamp":1786127424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-64529-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["64529"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-64529-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24532"}}